Cupid , a leading manufacturer of male and female condoms, and holding the distinction of being the first  Indian company to get WHO/UNFP prequalification, is grabbing a lot of attention on the bourses and this is thanks to its very good performance for Q4FY16. The company’s total income rose 40% (YoY) at Rs.18 crore. The increase in sales was largely on account of sales in new territories as well as uptick in the revenue from its contract manufacturing business. The contract manufacturing sales contributed close to 20% in the overall revenues. EBITDA stood at Rs.9 crore, up by a whopping 121% and margins are very healthy at 48.5% for Q4FY16 as against 30.7% in Q4FY15.

Net profit stood at Rs.5 crore, up 262%. This debt free company has a small equity base of Rs.9.71 crore.

The company has signed a non-exclusive long term agreement with United Nations Population Fund(UNFPA) for supplying female condoms over the next 3 years. In addition, the company also received order worth Rs.103 crore from National department of Health (NDOH), South Africa. The execution from this agreement is already underway and will complete through fiscal 2018-19.